In this case study, discover how Parexel takes on the most operationally complex prostate cancer trials — delivering with confidence, speed, and control to de-risk pivotal programs, accelerate ...

New findings from VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM), published in Pharmacological Research, show that an innovative drug effectively prevents ...

A 64-year-old with advanced prostate cancer underwent robotic surgery after hormonal therapy, achieving successful tumour ...

NEWTOWN, Conn., March 31, 2026 /PRNewswire/ -- Elidah today announced FDA clearance of Elitone for Men, a non-invasive, at-home treatment designed to help men regain bladder control after prostate ...

University of Miami researchers found that type 2 diabetes drug metformin can help cancer patients by activating a molecule ...

A father whose life was severely impacted by an enlarged prostate, causing him to urinate up to 18 times a day, has described ...

The MarketWatch News Department was not involved in the creation of this content. First and only non-invasive, Medicare-covered at-home therapy for post-prostatectomy urinary incontinence-- available ...

A recent randomized clinical trial has found that men with localized, intermediate-risk prostate cancer recovered faster and experienced less short-term impact on their daily lives when treated with ...

Men with prostate cancer are to be the subjet of a major new all-Ireland trial which aims to reduce the side-effects of ...

Novartis (NVS) stock is in focus as the company withdraws its bid to expand the label for its radiotherapy Pluvicto for a type of prostate cancer in the EU. Read more here.

Mark Oliver, 67, says a revolutionary treatment has significantly improved his life ...